ConductScience.org, home

Paper19783989

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

Fife BT and 8 others. Nat Immunol, 2009. Cited by 625 papers, by iCite.

Cite this record

ConductScience Library. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Papers, record 19783989. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19783989

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
PubMed
Journal
Nat Immunol
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
625
iCite
Relative citation ratio, by iCite
11.8
iCite
Revised in PubMed
2025-05-29
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fife BTBrian T
2Pauken KEKristen E
3Eagar TNTodd N
4Obu TTakashi
5Wu JJenny
6Tang QQizhi
7Azuma MMiyuki
8Krummel MFMatthew F
9Bluestone JAJeffrey A

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, SurfaceMajor topic
Apoptosis Regulatory ProteinsMajor topic
B7-1 AntigenMajor topic
Immune ToleranceMajor topic
Membrane GlycoproteinsMajor topic
PeptidesMajor topic
Receptors, Antigen, T-CellMajor topic
Signal TransductionMajor topic
Animals
Antigens, CD
B7-H1 Antigen
CTLA-4 Antigen
Cell Movement
Dendritic Cells
Diabetes Mellitus, Experimental
Diabetes Mellitus, Type 1
Islets of Langerhans
Islets of Langerhans Transplantation
Lymphocyte Activation
Mice
Mice, Inbred C57BL
Mice, Inbred NOD
Mice, Transgenic
Programmed Cell Death 1 Receptor

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 AI035297NIAID NIH HHSUnited StatesP01AI035297PubMed and NIHNIH RePORTER
P30 DK063720NIDDK NIH HHSUnited StatesP30DK063720PubMed and NIHNIH RePORTER
AI35297NIAID NIH HHSUnited StatesP01AI035297PubMed and NIHNIH RePORTER
P30 DK63720NIDDK NIH HHSUnited StatesP30DK063720PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in20218851Making antigen invisible: a coinhibitory molecule regulates the interaction between T cells and dendritic cells.https://conductscience.org/library/papers/20218851

Source PubMed

Download CSV of comments and corrections

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116382236Restoring function in exhausted CD8 T cells during chronic viral infection.Nature2006https://conductscience.org/library/papers/16382236PubMed
27584144Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.Immunity1995https://conductscience.org/library/papers/7584144PubMed
318759926Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.Immunol Rev2008https://conductscience.org/library/papers/18759926PubMed
417112751Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes.Immunity2006https://conductscience.org/library/papers/17112751PubMed
516931720Reversal of the TCR stop signal by CTLA-4.Science2006https://conductscience.org/library/papers/16931720PubMed
612016203Two-photon imaging of lymphocyte motility and antigen response in intact lymph node.Science2002https://conductscience.org/library/papers/12016203PubMed
716227604CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.Mol Cell Biol2005https://conductscience.org/library/papers/16227604PubMed
812161284Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.Immunol Lett2002https://conductscience.org/library/papers/12161284PubMed
912086671Transcriptional mechanisms underlying lymphocyte tolerance.Cell2002https://conductscience.org/library/papers/12086671PubMed
1015357946Dynamic behavior of T cells and thymocytes in lymphoid organs as revealed by two-photon microscopy.Immunity2004https://conductscience.org/library/papers/15357946PubMed
1115466619Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes.J Exp Med2004https://conductscience.org/library/papers/15466619PubMed
1217964663TCR/CD3 mediated stop-signal is decoupled in T-cells from Ctla4 deficient mice.Immunol Lett2008https://conductscience.org/library/papers/17964663PubMed
139796923Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses.Int Immunol1998https://conductscience.org/library/papers/9796923PubMed
149108078Antigen receptor engagement delivers a stop signal to migrating T lymphocytes.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9108078PubMed
1516799470Dynamic imaging of the immune system: progress, pitfalls and promise.Nat Rev Immunol2006https://conductscience.org/library/papers/16799470PubMed
168402882Following a diabetogenic T cell from genesis through pathogenesis.Cell1993https://conductscience.org/library/papers/8402882PubMed
1714712275T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.Nature2004https://conductscience.org/library/papers/14712275PubMed
1815516925Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity.Nat Immunol2004https://conductscience.org/library/papers/15516925PubMed
1918173375PD-1 and its ligands in tolerance and immunity.Annu Rev Immunol2008https://conductscience.org/library/papers/18173375PubMed
2012421930Expression of programmed death 1 ligands by murine T cells and APC.J Immunol2002https://conductscience.org/library/papers/12421930PubMed

See all 50 referencesDownload CSV of references

Cited by447

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 625 citations.

PMIDTitleJournalYearIn PapersSource
42761718Nanoadjuvant-based membrane poration boosts antitumor immunity via modulating mitochondrial metabolism to downregulate PD-L1 and upregulate STING.Bioact Mater2027https://conductscience.org/library/papers/42761718PubMed
42746516Immune context governs stage-specific responses to depleting anti-PD-1 antibody in type 1 diabetes.Cell Biomater2026https://conductscience.org/library/papers/42746516PubMed
42723817Using an artificial intelligence tool to improve the recognition of pseudoprogression in pleural mesothelioma patients treated with immunotherapy: a case series.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42723817PubMed
42680727Immune checkpoints and immunoregulation in metabolic diseases and cancers: pathological mechanisms and therapeutic potential.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42680727PubMed
42242923A "scan and stop" assay identifies CD40 and CD70 as selective regulators of T-cell arrest on APCs.Life Sci Alliance2026https://conductscience.org/library/papers/42242923PubMed
41932343Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment.Immunity2026https://conductscience.org/library/papers/41932343PubMed
41920992Beta cell-targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slices.Sci Adv2026https://conductscience.org/library/papers/41920992PubMed
41859117isMap - immunological synapse map analysis program.Front Immunol2026https://conductscience.org/library/papers/41859117PubMed
41782997Precise regulation of cancer vaccine and immune checkpoint inhibitor synergy potentiates immunotherapy with reduced immune-related pneumonitis.Mater Today Bio2026https://conductscience.org/library/papers/41782997PubMed
41586193Advances in cancer immunotherapy: Strategies and innovations strategies for adoptive immunotherapy of cancer.Iran J Basic Med Sci2025https://conductscience.org/library/papers/41586193PubMed
41449459Advanced nanotechnology in enhancing immune checkpoint inhibitors (ICIs) for head and neck cancer therapy.Cell Commun Signal2025https://conductscience.org/library/papers/41449459PubMed
41278996Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slices.bioRxiv2025https://conductscience.org/library/papers/41278996PubMed
41209702Recent advances in nanoparticles-based sonodynamic and immune checkpoint blockade synergistic therapy for pancreatic ductal adenocarcinoma.Mater Today Bio2025https://conductscience.org/library/papers/41209702PubMed
40925525Programmed death-ligand 1 on ex vivo-expanded toll-like-receptor-Bregs prevents allograft rejection by Breg viability promotion, CD4+ T effector cell suppression, and regulatory T cell induction.Am J Transplant2026https://conductscience.org/library/papers/40925525PubMed
40891582The Expanding Role of ILC2s in Allergic Airways Disease.Allergy2026https://conductscience.org/library/papers/40891582PubMed
40877509Enhancing Cancer Vaccine Efficacy: siRNA-Based Modulation of Immune Suppressive Factors in Dendritic Cells.Methods Mol Biol2025https://conductscience.org/library/papers/40877509PubMed
40759576ST8Sia6 overexpression protects pancreatic β cells from spontaneous autoimmune diabetes in nonobese diabetic mice.J Clin Invest2025https://conductscience.org/library/papers/40759576PubMed
40623940PD-1 expressing islet-specific CD4+ T cells promote bystander tolerance and prevent autoimmunity.Immunol Cell Biol2025https://conductscience.org/library/papers/40623940PubMed
40489506Agent-based modeling for personalized prediction of an experimental immune response to immunotherapeutic antibodies.PLoS One2025https://conductscience.org/library/papers/40489506PubMed
40427133Programmed Death-1 Ligand 1 Domain Organization, Signaling Motifs, and Interactors in Cancer Immunotherapy.Cancers (Basel)2025https://conductscience.org/library/papers/40427133PubMed

See all 447 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19783989

GET https://conductscience.org/api/papers/v1/19783989/references?page=2